クロルヘキシジン:WHOの必須医薬品である.

Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.

Nuclear medicine communications·1994

Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7.

Cancer research·1994

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.

International journal of cancer·1994

An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.

International journal of cancer·1992

Pancreaticojejunostomy for severe symptomatic chronic pancreatitis.

HPB surgery : a world journal of hepatic, pancreatic and biliary surgery·1992

Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.

Cancer research·1991

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

A Water-soluble Fluorescent Probe Based on Chitosan for Hypochlorite and Nitrite Detection.

Journal of fluorescence·2026

The Bidentate Adsorption Mode of Re-Ni Atomic Pairs Inducing the Ultralow Overpotential in CO2 Electroreduction.

Angewandte Chemie (International ed. in English)·2026

A Case of Exuberant Type 2 Pneumocyte Hyperplasia in a Young Man with Recurrent Spontaneous Pneumothorax: A Diagnostic Pitfall.

Surgical case reports·2026

NIR-driven ROS generation by carbon nitride heterojunctions enables selective detection of copper ions in whole blood.

Analytical methods : advancing methods and applications·2026

Charge-Transfer Reversal at Cl-Regulated Cu2O/in2S3 Interfaces Enables C─C Coupling for Selective CO2 Photoreduction to C2H4.

Advanced materials (Deerfield Beach, Fla.)·2026

Reduced mediators released by cyanobacteria during exoelectrogenesis detected using differential pulse voltammetry.

Bioelectrochemistry (Amsterdam, Netherlands)·2026

関連する実験動画

クロルヘキシジン:WHOの必須医薬品である.

関連する概念動画

Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.

Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7.

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.

An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.

Pancreaticojejunostomy for severe symptomatic chronic pancreatitis.

Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

A Water-soluble Fluorescent Probe Based on Chitosan for Hypochlorite and Nitrite Detection.

The Bidentate Adsorption Mode of Re-Ni Atomic Pairs Inducing the Ultralow Overpotential in CO<sub>2</sub> Electroreduction.

A Case of Exuberant Type 2 Pneumocyte Hyperplasia in a Young Man with Recurrent Spontaneous Pneumothorax: A Diagnostic Pitfall.

NIR-driven ROS generation by carbon nitride heterojunctions enables selective detection of copper ions in whole blood.

Charge-Transfer Reversal at Cl-Regulated Cu<sub>2</sub>O/in<sub>2</sub>S<sub>3</sub> Interfaces Enables C─C Coupling for Selective CO<sub>2</sub> Photoreduction to C<sub>2</sub>H<sub>4</sub>.

Reduced mediators released by cyanobacteria during exoelectrogenesis detected using differential pulse voltammetry.

関連する実験動画

クロルヘキシジン:WHOの必須医薬品である.

関連する概念動画

関連記事